{"id":"https://openalex.org/W52103172","doi":null,"title":"Managing toxicities of high-dose interleukin-2.","display_name":"Managing toxicities of high-dose interleukin-2.","publication_year":2002,"publication_date":"2002-11-01","ids":{"openalex":"https://openalex.org/W52103172","mag":"52103172","pmid":"https://pubmed.ncbi.nlm.nih.gov/12469935"},"language":"en","primary_location":{"id":"pmid:12469935","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12469935","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035033017","display_name":"Rowena N Schwartz","orcid":"https://orcid.org/0000-0002-6088-2549","observed_orcids":["https://orcid.org/0000-0002-6088-2549"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rowena N Schwartz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056340513","display_name":"L. L. Stover","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lori Stover","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5033346506","display_name":"Janice P. Dutcher","orcid":"https://orcid.org/0000-0002-2267-9187","observed_orcids":["https://orcid.org/0000-0002-2267-9187"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janice P Dutcher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.184,"has_fulltext":false,"cited_by_count":229,"citation_normalized_percentile":{"value":0.7719691,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"16","issue":"11 Suppl 13","first_page":"11","last_page":"20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.3337000012397766,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10449","display_name":"Renal cell carcinoma treatment","score":0.3337000012397766,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.24009999632835388,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.1062999963760376,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-dose-interleukin-2","display_name":"high-dose interleukin-2","score":0.925000011920929},{"id":"https://openalex.org/keywords/il-2-toxicity","display_name":"IL-2 toxicity","score":0.8479999899864197},{"id":"https://openalex.org/keywords/capillary-leak","display_name":"capillary leak syndrome","score":0.9950000047683716},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.7279999852180481},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":1.0},{"id":"https://openalex.org/keywords/toxicity-management","display_name":"toxicity management","score":0.652999997138977},{"id":"https://openalex.org/keywords/patient-selection-criteria","display_name":"patient selection criteria","score":0.777999997138977},{"id":"https://openalex.org/keywords/hypovolemia","display_name":"hypovolemia","score":0.6620000004768372},{"id":"https://openalex.org/keywords/oliguria","display_name":"oliguria","score":0.7680000066757202},{"id":"https://openalex.org/keywords/central-nervous-system-toxicity","display_name":"central nervous system toxicity","score":0.777999997138977},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.42899999022483826},{"id":"https://openalex.org/keywords/pulmonary-toxicity","display_name":"pulmonary toxicity","score":0.8240000009536743},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8617609143257141},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6484102606773376},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4911944568157196},{"id":"https://openalex.org/C2779744138","wikidata":"https://www.wikidata.org/wiki/Q961326","display_name":"Oliguria","level":3,"score":0.4710001051425934},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30936676263809204},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.15264949202537537}],"mesh":[{"descriptor_ui":"D000075202","descriptor_name":"Contraindications","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002292","descriptor_name":"Carcinoma, Renal Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007680","descriptor_name":"Kidney Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:12469935","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12469935","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology (Williston Park, N.Y.)","raw_type":"Journal Article"},{"id":"mag:52103172","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12469935","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W110661968","https://openalex.org/W1768088721","https://openalex.org/W1964032970","https://openalex.org/W1967884480","https://openalex.org/W1984044433","https://openalex.org/W1984521423","https://openalex.org/W1990004963","https://openalex.org/W1995525329","https://openalex.org/W2018146785","https://openalex.org/W2028650739","https://openalex.org/W2029286945","https://openalex.org/W2035069582","https://openalex.org/W2055584826","https://openalex.org/W2065514701","https://openalex.org/W2082742146","https://openalex.org/W2089169276","https://openalex.org/W2109177699","https://openalex.org/W2123914905","https://openalex.org/W2133988080","https://openalex.org/W2260176825","https://openalex.org/W2328390172","https://openalex.org/W2410698218","https://openalex.org/W2418019024","https://openalex.org/W2418327671"],"related_works":["https://openalex.org/W2324605323","https://openalex.org/W2323461292","https://openalex.org/W1984521423","https://openalex.org/W2082742146","https://openalex.org/W2590515720","https://openalex.org/W2041231796","https://openalex.org/W1904436785","https://openalex.org/W7140175150","https://openalex.org/W2017563355","https://openalex.org/W4410901806"],"abstract_inverted_index":{"Although":[0],"high-dose":[1,124,169,188],"interleukin-2":[2],"(IL-2,":[3],"Proleukin),":[4],"a":[5,96],"highly":[6],"toxic":[7],"agent":[8,57],"used":[9],"in":[10,27,69,95,102],"the":[11,28,42,75,103,182],"treatment":[12],"of":[13,46,87,114,123,127,148,187],"renal":[14],"cell":[15],"carcinoma":[16],"and":[17,44,58,62,79,99,117,120,136,151,160,172,176,184],"melanoma,":[18],"was":[19],"initially":[20],"associated":[21,37],"with":[22,38,55,163],"treatment-related":[23],"mortality,":[24],"it":[25],"can,":[26],"appropriate":[29],"setting,":[30],"be":[31],"administered":[32],"safely.":[33],"High-dose":[34],"IL-2":[35,65,88,125,170],"is":[36,90],"significant":[39],"morbidity;":[40],"however,":[41],"incidence":[43],"severity":[45],"toxicities":[47,171],"have":[48,52],"decreased":[49],"as":[50],"clinicians":[51],"gained":[53],"experience":[54],"this":[56],"implemented":[59],"toxicity":[60,66,89],"prevention":[61],"management":[63,174],"strategies.":[64],"can":[67,109],"manifest":[68],"multiple":[70],"organ":[71],"systems,":[72],"most":[73,84],"significantly":[74,111],"heart,":[76],"lungs,":[77],"kidneys,":[78],"central":[80],"nervous":[81],"system.":[82],"The":[83],"common":[85],"manifestation":[86],"capillary":[91],"leak":[92,107],"syndrome,":[93],"resulting":[94],"hypovolemic":[97],"state":[98],"fluid":[100],"accumulation":[101],"extravascular":[104],"space.":[105],"Capillary":[106],"syndrome":[108],"contribute":[110],"to":[112,142,157,180],"development":[113],"oliguria,":[115],"ischemia,":[116],"confusion.":[118],"Safe":[119],"effective":[121,185],"administration":[122,132,150,158,186],"consists":[126],"five":[128],"key":[129],"components:":[130],"(1)":[131],"by":[133],"an":[134],"experienced":[135],"knowledgeable":[137],"health-care":[138],"team,":[139],"(2)":[140],"adherence":[141,156],"strict":[143],"patient-eligibility":[144],"criteria,":[145,159],"(3)":[146],"implementation":[147],"standardized":[149],"patient":[152],"assessment":[153],"guidelines,":[154],"(4)":[155],"(5)":[161],"compliance":[162],"retreatment":[164],"contraindications.":[165],"This":[166],"article":[167],"reviews":[168],"symptom":[173],"strategies":[175],"provides":[177],"practical":[178],"guidelines":[179],"facilitate":[181],"safe":[183],"IL-2.":[189]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":19},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":20},{"year":2017,"cited_by_count":18},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}